Author:
Hao Mengze,Song Fengju,Du Xiaoling,Wang Guowen,Yang Yun,Chen Kexin,Yang Jilong
Funder
National Nature Science Foundation of China
University Cancer Foundation
Reference91 articles.
1. Cancer statistics, 2013;Siegel;CA Cancer J. Clin,2013
2. Cancer statistics, 2012;Siegel;CA Cancer J. Clin,2012
3. A phase II trial of sorafenib in metastatic melanoma with tissue correlates;Ott;PLoS ONE,2010
4. Phase II study of vemurafenib in patients with locally advanced, unresectable stage IIIc or metastatic melanoma and activating exon 15 BRAF mutations other than V600E;Sorof;J. Clin. Oncol. (Meeting Abstracts),2014
5. Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial;Long;Lancet Oncol,2012
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献